# Glutamine enhances endothelial cell survival and vasodilation by increasing glutathione to reduce oxidative stress

**Authors:** Marzyeh Kheradmand, Gurneet Sangha, Claire M. Sissons, Michael Sun, Xinyao Zhou, Lauren V. Smith, Meagan Bauer, Chengpeng Chen, Alisa Morss Clyne

PMC · DOI: 10.14814/phy2.70737 · 2026-01-21

## TL;DR

Glutamine helps protect blood vessel cells from damage caused by high sugar levels, potentially reducing heart disease risks in diabetes.

## Contribution

This study reveals that glutamine reduces oxidative stress in endothelial cells, improving cell survival and vasodilation in high glucose conditions.

## Key findings

- Glutamine increased endothelial cell proliferation by up to 3.5-fold regardless of glucose concentration.
- Glutamine metabolism reduced oxidative stress and cell death by up to 70% and 94%, respectively.
- Glutamine enhanced ex vivo vasodilation in murine carotid arteries without affecting eNOS activity.

## Abstract

Cardiovascular disease is exacerbated by diabetes through hyperglycemia‐induced endothelial dysfunction, which arises from oxidative stress. Glutamine is postulated to decrease oxidative stress; however, its effect on endothelial dysfunction in hyperglycemia is unknown. Therefore, we investigated how glutamine affects endothelial function in normal and high glucose. Human coronary artery endothelial cells were treated with 0, 0.5, or 2 mM glutamine in 5.5 or 15 mM glucose for 24 h. We then assessed cell proliferation, oxidative stress, cell survival, and endothelial nitric oxide synthase (eNOS) activity. Our data showed that independent of glucose concentration, glutamine increased proliferation by up to 3.5‐fold. Furthermore, glutamine metabolism through glutaminase‐1 reduced oxidative stress and cell death by up to 70% and 94%, respectively, by doubling glutathione and NADPH. Glutamine also increased ex vivo vasodilation in isolated murine carotid arteries without altering eNOS activity or nitric oxide in vitro, suggesting that the enhanced vasodilation results from reduced oxidative stress. These findings indicate that glutamine mitigates endothelial cell oxidative stress by enhancing reducing capacity, which may protect against diabetic cardiovascular disease.

## Linked entities

- **Chemicals:** glutamine (PubChem CID 738), glutathione (PubChem CID 124886), NADPH (PubChem CID 5884)
- **Diseases:** diabetes (MONDO:0005015), cardiovascular disease (MONDO:0004995)
- **Species:** Mus musculus (taxon 10090)

## Full-text entities

- **Genes:** NOS3 (nitric oxide synthase 3) [NCBI Gene 4846] {aka EC-NOS, ECNOS, MYMY8, NOSIII, cNOS, eNOS}, ME1 (malic enzyme 1) [NCBI Gene 4199] {aka HUMNDME, MES}, GSR (glutathione-disulfide reductase) [NCBI Gene 2936] {aka CNSHA10, GR, GSRD, HEL-75, HEL-S-122m}, GSTK1 (glutathione S-transferase kappa 1) [NCBI Gene 373156] {aka GST, GST 13-13, GST13, GST13-13, GSTK1-1, hGSTK1}, GCLC (glutamate-cysteine ligase catalytic subunit) [NCBI Gene 2729] {aka CNSHA7, GCL, GCS, GLCL, GLCLC}, GLS (glutaminase) [NCBI Gene 2744] {aka AAD20, CASGID, DEE71, EIEE71, GAC, GAM}, FGF2 (fibroblast growth factor 2) [NCBI Gene 2247] {aka BFGF, FGF-2, FGFB, HBGF-2}, CCNA2 (cyclin A2) [NCBI Gene 890] {aka CCN1, CCNA}, HEBP1 (heme binding protein 1) [NCBI Gene 50865] {aka HBP, HEBP}, HMOX1 (heme oxygenase 1) [NCBI Gene 3162] {aka HMOX1D, HO-1, HSP32, bK286B10}, GSS (glutathione synthetase) [NCBI Gene 2937] {aka CNSHA6, GSHS, HEL-S-64p, HEL-S-88n}, IDH1 (isocitrate dehydrogenase (NADP(+)) 1) [NCBI Gene 3417] {aka HEL-216, HEL-S-26, IDCD, IDH, IDP, IDPC}, Nos3 (nitric oxide synthase 3, endothelial cell) [NCBI Gene 18127] {aka 2310065A03Rik, Nos-3, eNOS, ecNOS}, NFE2L2 (NFE2 like bZIP transcription factor 2) [NCBI Gene 4780] {aka IMDDHH, NRF2, Nrf-2}
- **Diseases:** CMS (MESH:C536089), CVD (MESH:D002318), diabetes (MESH:D003920), inflammatory (MESH:D007249), hyperglycemic (MESH:D006944), endothelial dysfunction (MESH:D014652), Hyperglycemia (MESH:D006943), mitochondrial dysfunction (MESH:D028361), type 1 and type 2 diabetes (MESH:D003924)
- **Chemicals:** acids (MESH:D000143), L-arginine (MESH:D001120), ROS (MESH:D017382), Nitrite (MESH:D009573), paraformaldehyde (MESH:C003043), polyol (MESH:C024617), Bis-2-(5-phenylacetamido-1,2,4-thiadiazol-2-yl)ethyl sulfide (MESH:C523193), malate (MESH:C030298), Triton X-100 (MESH:D017830), penicillin (MESH:D010406), BP (MESH:C038809), carbons (MESH:D002244), polystyrene (MESH:D011137), streptomycin (MESH:D013307), HEPES (MESH:D006531), tBHP (MESH:D020122), yoda1 (MESH:C000708435), Isocitrate (MESH:C034219), water (MESH:D014867), NADP (MESH:D009249), beta-hydroxy-beta-methylbutyrate (MESH:C004961), asparagine (MESH:D001216), PBS (MESH:D007854), phenylephrine (MESH:D010656), CO2 (MESH:D002245), TCA (MESH:D014233), L-NAME (MESH:D019331), carbogen (MESH:C011700), D-glucose (MESH:D005947), DAPI (MESH:C007293), methanol (MESH:D000432), acetylcholine (MESH:D000109), HCl (MESH:D006851), formic acid (MESH:C030544), pyruvate (MESH:D019289), Calcein AM (MESH:C085925), H2DCFDA (MESH:C110400), GSH (MESH:D005978), O2 (MESH:D013481), GSSG (MESH:D019803), Alexa Fluor 488 (MESH:C000711379), Glutamate (MESH:D018698), phenol red (MESH:D010637), free fatty acids (MESH:D005230), B (MESH:D001895), EthD-1 (MESH:C018533), ammonia (MESH:D000641), alpha-ketoglutarate (MESH:D007656), PS (MESH:D010758), citrate (MESH:D019343), hexosamine (MESH:D006595), nitric oxide (MESH:D009569), Luciferin (MESH:D000090562), G4251 (-), Glutamine (MESH:D005973), Nitrate (MESH:D009566), acetonitrile (MESH:C032159)
- **Species:** Mus musculus (house mouse, species) [taxon 10090], Homo sapiens (human, species) [taxon 9606]
- **Mutations:** glutamine to glutamate
- **Cell lines:** CLS3917 — Homo sapiens (Human), Rhabdoid tumor of the kidney, Cancer cell line (CVCL_5904)

## Figures

6 figures with captions in the complete paper: https://tomesphere.com/paper/PMC12824527/full.md

---
Source: https://tomesphere.com/paper/PMC12824527